Workflow
Alzamend Neuro(ALZN) - 2025 Q4 - Annual Results
Alzamend NeuroAlzamend Neuro(US:ALZN)2025-07-23 20:30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ___________________________________________________________________ Date of Report (Date of earliest event reported): July 23, 2025 Washington, D.C. 20549 ____________________________________________________________ FORM 8-K ALZAMEND NEURO, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Securities re ...